Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Frankfurt Thrombophilia Registry

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Prof. Dr. med. E. Lindhoff-Last, Cardioangiologisches Centrum Bethanien
ClinicalTrials.gov Identifier:
NCT00683397
First received: May 21, 2008
Last updated: November 10, 2016
Last verified: November 2016
  Purpose
Consecutive patients with acute or previous venous thromboembolism are enrolled in this registry. Using a standardized questionnaire, clinical data detailing venous thromboembolism and contributing VTE risk factors are recorded. Results of technical and laboratory investigations including screening for thrombophilic disorders were additionally entered into the database.

Condition Intervention
Venous Thromboembolism
Other: Blood sampling

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Frankfurt Thrombophilia Registry - Evaluation of Patients With Venous Thromboembolism

Resource links provided by NLM:


Further study details as provided by Cardioangiologisches Centrum Bethanien:

Biospecimen Retention:   Samples With DNA
whole blood, serum

Enrollment: 2000
Study Start Date: May 2008
Study Completion Date: December 2014
Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
A
Patients with acute or previous venous thromboembolism >18 years of age
Other: Blood sampling
Screening of thrombophilia

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
consecutive patients with acute or previous VTE >18 years of age
Criteria

Inclusion Criteria:

  • Acute or previous VTE

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00683397

Locations
Germany
Cardioangiologisches Centrum Bethanien
Frankfurt/Main, Hessen, Germany, 60389
Sponsors and Collaborators
Cardioangiologisches Centrum Bethanien
Investigators
Principal Investigator: Edelgard Lindhoff-Last, Professor Cardioangiologisches Zentrum Bethanien
  More Information

Responsible Party: Prof. Dr. med. E. Lindhoff-Last, M.D., Cardioangiologisches Centrum Bethanien
ClinicalTrials.gov Identifier: NCT00683397     History of Changes
Other Study ID Numbers: MAISTHRO Study 93/08 
Study First Received: May 21, 2008
Last Updated: November 10, 2016
Health Authority: Germany: Ethics Commission

Keywords provided by Cardioangiologisches Centrum Bethanien:
assess
prevalence
thrombophilia
common
VTE
risk factors
patients

Additional relevant MeSH terms:
Thromboembolism
Venous Thromboembolism
Thrombophilia
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Hematologic Diseases

ClinicalTrials.gov processed this record on December 08, 2016